Similar articles

• Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer.

  Davidson NE, Morrow M. Davidson NE, et al. J Natl Cancer Inst. 2005 Feb 2;97(3):159-61. doi: 10.1093/jnci/dji049. J Natl Cancer Inst. 2005. PMID: 15687353 No abstract available.
• [Adjuvant therapy in breast cancer].

  Semiglazov VF. Semiglazov VF. Vopr Onkol. 2000;46(1):18-27. Vopr Onkol. 2000. PMID: 10789218 Review. Russian. No abstract available.
• Treatment of advanced breast cancer: How much chemotherapy is enough?

  DiPaola RS, Kaufman A, Mikhail MM. DiPaola RS, et al. Semin Oncol. 1996 Jun;23(3):xv-xxii; discussion xxii-xxiv. Semin Oncol. 1996. PMID: 8658211 No abstract available.
• [Features and risk factors of post-mastectomy, locally advanced breast cancer relapse].

  Kharchenko VP, Khmelevskiĭ EV, Chkhikvadze VD, Bozhenko VK, Pan'shin GA, Kolesnikov RV. Kharchenko VP, et al. Vopr Onkol. 2009;55(4):436-42. Vopr Onkol. 2009. PMID: 19947366 Russian.
• [Adjuvant therapy of breast cancer].

  Semiglazov VF, Abzumanov AS, Bozhok AA, Ivanov VG, Ivanova OA, Barash NIu, Topuzov EE, Seleznev IK, Migmanova NSh, Popova RT, Nurgaziev KSh. Semiglazov VF, et al. Khirurgiia (Mosk). 2001;(5):52-60. Khirurgiia (Mosk). 2001. PMID: 11505673 Review. Russian. No abstract available.